Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where excess fat accumulates in the liver, not due to alcohol consumption. This term is a new name for what was previously known as non-alcoholic fatty liver disease (NAFLD) and emphasizes its connection to metabolic health problems, such as obesity and diabetes.
Understanding MASLD is important because it can lead to more serious liver issues, including inflammation and liver damage. With the rising rates of obesity and diabetes globally, the prevalence of MASLD is increasing, making it a significant public health concern. If not addressed, it can progress to more severe liver diseases, affecting overall health.
The liver plays a crucial role in processing nutrients, filtering toxins, and producing important proteins. When fat builds up in the liver, it can disrupt these functions, leading to health issues. The body may struggle to regulate blood sugar and break down fats properly, which can worsen metabolic health.
Recognizing MASLD is vital for early intervention and management. Although it does not always cause symptoms in the early stages, awareness of the condition can lead to better health outcomes through lifestyle changes and monitoring metabolic health.